Global Starch Capsules Market Analysis 2021-2028
Starch capsules, which are used as an alternative to the conventional gelatin-based empty capsules, are made up of starch as its raw material. These capsules are known to possess numerous benefits over the conventional capsules, such as low moisture content, low static charge, low humidity levels and others, which helps to keep the contents inside the capsules safer. The global starch capsules market is anticipated to grow with a CAGR of 5.14% during the forecast period, i.e. 2021-2028. Factors such as increasing incidences of various diseases, which is driving the demand for pharmaceuticals and nutraceuticals, coupled with the growing technological innovations, increasing awareness among the scientific community regarding the development of sustainable and drug compatible capsule products are anticipated to promote the market growth. Additionally, factors such as the growing healthcare expenditure by both public and private entities around the globe, along with the rising demand for advanced pharmaceuticals which have an efficient alternative delivery system, especially for orally administered compounds, are anticipated to drive the growth of the global starch capsules market during the forecast period.
The market is segmented by end user into pharmaceutical, cosmeceutical and nutraceutical companies, out of which, the pharmaceutical industry segment is anticipated to grow with a CAGR of around 7% during the forecast period. Factors such as the rising need for advanced pharmaceuticals, growing research and developments in the pharmaceutical industry, backed by the rising healthcare expenditures, are anticipated to drive the growth of the segment.
Based on region, the global starch capsules market is segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa, out of which, market in North America, which registered a share of around 38% in the year 2019, is anticipated to hold the largest market share during the forecast period. The players operating in the pharmaceutical industry in North America has the most strategic partnership and have access to high quality medications and healthcare awareness.
Some of the affluent industry leaders in the global starch capsules market are Capsugel (a Lonza Company), Farmacapsulas S.A., Dah Feng Capsule Industry Co., Ltd., ACG, Meihua Holdings Group Co., Ltd., GoCaps, Shaoxing Kangke Capsule Co., Ltd., and Suheung Co., Ltd.
Starch capsules, which are used as an alternative to the conventional gelatin-based empty capsules, are made up of starch as its raw material. These capsules are known to possess numerous benefits over the conventional capsules, such as low moisture content, low static charge, low humidity levels and others, which helps to keep the contents inside the capsules safer. The global starch capsules market is anticipated to grow with a CAGR of 5.14% during the forecast period, i.e. 2021-2028. Factors such as increasing incidences of various diseases, which is driving the demand for pharmaceuticals and nutraceuticals, coupled with the growing technological innovations, increasing awareness among the scientific community regarding the development of sustainable and drug compatible capsule products are anticipated to promote the market growth. Additionally, factors such as the growing healthcare expenditure by both public and private entities around the globe, along with the rising demand for advanced pharmaceuticals which have an efficient alternative delivery system, especially for orally administered compounds, are anticipated to drive the growth of the global starch capsules market during the forecast period.
The market is segmented by end user into pharmaceutical, cosmeceutical and nutraceutical companies, out of which, the pharmaceutical industry segment is anticipated to grow with a CAGR of around 7% during the forecast period. Factors such as the rising need for advanced pharmaceuticals, growing research and developments in the pharmaceutical industry, backed by the rising healthcare expenditures, are anticipated to drive the growth of the segment.
Based on region, the global starch capsules market is segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa, out of which, market in North America, which registered a share of around 38% in the year 2019, is anticipated to hold the largest market share during the forecast period. The players operating in the pharmaceutical industry in North America has the most strategic partnership and have access to high quality medications and healthcare awareness.
Some of the affluent industry leaders in the global starch capsules market are Capsugel (a Lonza Company), Farmacapsulas S.A., Dah Feng Capsule Industry Co., Ltd., ACG, Meihua Holdings Group Co., Ltd., GoCaps, Shaoxing Kangke Capsule Co., Ltd., and Suheung Co., Ltd.
Table of Contents
Global Starch Capsules Market1. Introduction2. Assumptions And Acronyms3. Research Methodology4. Analyst Review5. Executive Summary - Global Starch Capsule Market6. Regulatory & Standards Landscape9. Major Roadblocks For The Market Growth10. Impact Of Covid-19 On The Starch Capsule Market11. Key Market Opportunities12. Assessment Of End Users Of Starch Capsule13. Comparative Analysis Of Capsule Materials14. Analysis On The Starch Capsule Ecosystem
7. Starch Capsule -Risk Analysis
8. Analysis Of Market Dynamics
15. Competitive Structure
16. Global Starch Capsule Market Outlook
17. Asia Pacific Starch Capsule Market Outlook, 2019-2028
18. North America Starch Capsule Market Outlook, 2019-2028
19. Europe Starch Capsule Market Outlook, 2019-2028
20. Latin America Starch Capsule Market Outlook, 2019-2028
21. Middle East & Africa Starch Capsule Market Outlook, 2019-2028
Companies Mentioned
- Capsugel (a Lonza Company)
- Farmacapsulas S.A.
- Dah Feng Capsule Industry Co. Ltd.
- ACG
- Meihua Holdings Group Co. Ltd.
- GoCaps
- Shaoxing Kangke Capsule Co. Ltd.
- Suheung Co. Ltd.